Influence of autoantibodies against AT1 receptor and AGTR1 polymorphisms on candesartan-based antihypertensive regimen
- 15 October 2013
- journal article
- Published by Elsevier in Journal of the American Society of Hypertension
- Vol. 8 (1) , 21-27
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodiesHeart, 2011
- Angiotensin Receptor Agonistic Autoantibody Is Highly Prevalent in PreeclampsiaHypertension, 2010
- Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant miceNature Medicine, 2008
- Association Between Angiotensinogen, Angiotensin II Receptor Genes, and Blood Pressure Response to an Angiotensin-Converting Enzyme InhibitorCirculation, 2007
- SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism lociCell Research, 2005
- Angiotensinogen Gene Haplotype and HypertensionHypertension, 2003
- Evidence for Involvement of the Type 1 Angiotensin II Receptor Locus in Essential HypertensionHypertension, 1999
- Association of angiotensin II type 1 receptor gene polymorphism with essential hypertensionClinical Genetics, 1997
- Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension.Hypertension, 1994
- The immune system and hypertension.Hypertension, 1992